UA97384U - Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system - Google Patents

Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system

Info

Publication number
UA97384U
UA97384U UAU201411057U UAU201411057U UA97384U UA 97384 U UA97384 U UA 97384U UA U201411057 U UAU201411057 U UA U201411057U UA U201411057 U UAU201411057 U UA U201411057U UA 97384 U UA97384 U UA 97384U
Authority
UA
Ukraine
Prior art keywords
treatment
connective
pathology
patients
gastrointestinal tract
Prior art date
Application number
UAU201411057U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Iryna Petrivna Shmakova
Yuliia Viktorivna Prokopchuk
Original Assignee
Univ Odesa Nat Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Odesa Nat Medical filed Critical Univ Odesa Nat Medical
Priority to UAU201411057U priority Critical patent/UA97384U/en
Publication of UA97384U publication Critical patent/UA97384U/en

Links

Landscapes

  • Electrotherapy Devices (AREA)

Abstract

Спосіб лікування хворих із сполучною патологією шлунково-кишкового тракту і серцево-судинної системи здійснюють шляхом застосування медикаментозної і фізіотерапій. На тлі традиційної медикаментозної терапії як фізіовплив призначають мезодіенцефальну електромодуляцію. Електромодуляцію здійснюють з генерацією прямокутних імпульсів струму тривалістю 4 мс, фіксованою частотою 80 імп. сабо модульованою в діапазоні 60-80 імп. с, з амплітудою вихідного струму, яка не перевищує 2,5 мА, тривалістю впливу від 15 хв до 30 хв, курс лікування 10-12 процедур, при необхідності курс повторюють 2-3 місяці.The method of treatment of patients with connective pathology of the gastrointestinal tract and cardiovascular system is carried out by the use of medication and physiotherapy. Against the backdrop of traditional drug therapy, mesodiaencephalic electromodulation is prescribed as a physiotherapy effect. Electromodulation is performed with the generation of rectangular current pulses of 4 ms duration, a fixed frequency of 80 pulses. clogs modulated in the range of 60-80 imp. C, with an output current amplitude not exceeding 2.5 mA, duration of exposure from 15 min to 30 min, course of treatment 10-12 procedures, if necessary, repeat the course for 2-3 months.

UAU201411057U 2014-10-10 2014-10-10 Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system UA97384U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201411057U UA97384U (en) 2014-10-10 2014-10-10 Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201411057U UA97384U (en) 2014-10-10 2014-10-10 Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system

Publications (1)

Publication Number Publication Date
UA97384U true UA97384U (en) 2015-03-10

Family

ID=52990547

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201411057U UA97384U (en) 2014-10-10 2014-10-10 Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system

Country Status (1)

Country Link
UA (1) UA97384U (en)

Similar Documents

Publication Publication Date Title
PH12016501618A1 (en) Anti-dll3 antibodies and drug conjugates for use in melanoma
MX2016000173A (en) Systems and methods for tracking and presenting tinnitus therapy data.
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
TW201613636A (en) Methods of treating Alzheimer's Disease
MX2021004558A (en) Proton-binding polymers for oral administration.
EA201890002A1 (en) POSITIVE ALLOSTERIC MODULATORS OF MUSCARINE M2 RECEPTOR
MA40535A (en) Hsp90-targeted inflammation and infection imaging and therapy
EA201890457A1 (en) COMBINATION ANTIBODY AGAINST THE OX40 AND THE TLR4 MODULATOR AND THEIR APPLICATION
CY1119532T1 (en) (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
EA201690997A1 (en) COMPOSITION FOR APPLICATION IN THE TREATMENT OF PERSISTENT Cough
MX2017000141A (en) Targeted therapeutic nanoparticles and methods of making and using same.
CY1119522T1 (en) (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
FR3045392B1 (en) DEVICE FOR THE TREATMENT OF A SUBJECT BY COMBINING IN PARTICULAR LITHOTHERAPY, CHROMOTHERAPY, LUMINOTHERAPY AND MUSIC THERAPY
UA97384U (en) Method for the treatment of patients with connective pathology of the gastrointestinal tract and the cardiovascular system
EA201301080A1 (en) APPLICATION OF SALTS OF 3-CARBOXY-N-ETHYL-N, N-DIMETHYLPROPAN-1-AMMONIUM IN TREATMENT OF CARDIOVASCULAR DISEASE
RU2014116784A (en) METHOD FOR TREATING PERIODONTAL DISEASES
RU2013129433A (en) METHOD FOR STIMULATION OF DETAINED DENTURES IN CUTTING PERMANENT TEETH
UA125728U (en) METHOD OF ATOPIC DERMATITIS TREATMENT
RU2014119669A (en) METHOD OF SUBSTRATE MUSCULAR BLOCKADE
UA96662U (en) METHOD OF TREATMENT OF Erectile Dysfunction in Patients with Chronic Prostatitis
EA201990411A1 (en) METHODS OF TREATING PROSTATE CANCER
UA118698C2 (en) METHOD OF URETEROCUTANEOSTOMY BY STAKHOVSKY
UA98604U (en) METHOD OF COMPLEX STAGE REHABILITATION OF PATIENTS IN LATE SINGLE PERIOD OF HEMORRAGIC TROUBLESHOOTING